Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions

Journal of Immunology

Volumn 186, Issue 4, 2011, Pages 2138-2147

  Paolino, Magdalena ^a   Thien, Christine B F ^b   Gruber, Thomas ^c   Hinterleitner, Reinhard ^c   Baier, Gottfried ^c   Langdon, Wallace Y ^b   Penninger, Josef M ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CBL B E3 LIGASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CATALYSIS; CELLULAR IMMUNITY; CLONAL ANERGY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME REGULATION; FEMALE; GENE INACTIVATION; GENE MUTATION; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; TUMOR CELL; TUMOR REJECTION; WART VIRUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; AUTOIMMUNE DISEASES; CELL LINE, TUMOR; CLONAL ANERGY; ENZYME ACTIVATION; FEMALE; GENE KNOCK-IN TECHNIQUES; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; POINT MUTATION; PROTO-ONCOGENE PROTEINS C-CBL; RING FINGER DOMAINS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; UBIQUITIN-PROTEIN LIGASES;

EID: 79951922287     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003390     Document Type: Article

References (42)

1. Bhoj, V. G., and Z. J. Chen. 2009. Ubiquitylation in innate and adaptive immunity. Nature 458: 430-437.
2. Paolino, M., and J. M. Penninger. 2009. E3 ubiquitin ligases in T-cell tolerance. Eur. J. Immunol. 39: 2337-2344.
3. Liu, Y. C., J. Penninger, and M. Karin. 2005. Immunity by ubiquitylation: a reversible process of modification. Nat. Rev. Immunol. 5: 941-952.
4. Pickart, C. M. 2001. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70: 503-533.
5. Welchman, R. L., C. Gordon, and R. J. Mayer. 2005. Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat. Rev. Mol. Cell Biol. 6: 599-609.
6. Bachmaier, K., C. Krawczyk, I. Kozieradzki, Y. Y. Kong, T. Sasaki, A. Oliveirados-Santos, S. Mariathasan, D. Bouchard, A. Wakeham, A. Itie, et al. 2000. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403: 211-216. (Pubitemid 30050966)
7. Chiang, Y. J., H. K. Kole, K. Brown, M. Naramura, S. Fukuhara, R. J. Hu, I. K. Jang, J. S. Gutkind, E. Shevach, and H. Gu. 2000. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403: 216-220. (Pubitemid 30050967)
8. Nau, M. M., and S. Lipkowitz. 2003. Comparative genomic organization of the cbl genes. Gene 308: 103-113. (Pubitemid 36597828)
9. Tsygankov, A. Y., A. M. Teckchandani, E. A. Feshchenko, and G. Swaminathan. 2001. Beyond the RING: CBL proteins as multivalent adapters. Oncogene 20: 6382-6402. (Pubitemid 32977846)
10. Schmidt, M. H., and I. Dikic. 2005. The Cbl interactome and its functions. Nat. Rev. Mol. Cell Biol. 6: 907-918.
11. Waterman, H., G. Levkowitz, I. Alroy, and Y. Yarden. 1999. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor. J. Biol. Chem. 274: 22151-22154.
12. Ettenberg, S. A., A. Magnifico, M. Cuello, M. M. Nau, Y. R. Rubinstein, Y. Yarden, A. M. Weissman, and S. Lipkowitz. 2001. Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex. J. Biol. Chem. 276: 27677-27684.
13. Joazeiro, C. A., S. S. Wing, H. Huang, J. D. Leverson, T. Hunter, and Y. C. Liu. 1999. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286: 309-312.
14. Zheng, N., P. Wang, P. D. Jeffrey, and N. P. Pavletich. 2000. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 102: 533-539.
15. Jeon, M. S., A. Atfield, K. Venuprasad, C. Krawczyk, R. Sarao, C. Elly, C. Yang, S. Arya, K. Bachmaier, L. Su, et al. 2004. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21: 167-177. (Pubitemid 39094047)
16. Gronski, M. A., J. M. Boulter, D. Moskophidis, L. T. Nguyen, K. Holmberg, A. R. Elford, E. K. Deenick, H. O. Kim, J. M. Penninger, B. Odermatt, et al. 2004. TCRaffinity and negative regulation limit autoimmunity. Nat. Med. 10: 1234-1239.
17. Chiang, J. Y., I. K. Jang, R. Hodes, and H. Gu. 2007. Ablation of Cbl-b provides protection against transplanted and spontaneous tumors. J. Clin. Invest. 117: 1029-1036.
18. Loeser, S., K. Loser, M. S. Bijker, M. Rangachari, S. H. van der Burg, T. Wada, S. Beissert, C. J. Melief, and J. M. Penninger. 2007. Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells. J. Exp. Med. 204: 879-891.
19. Fang, D., C. Elly, B. Gao, N. Fang,Y.Altman, C. Joazeiro, T. Hunter,N. Copeland, N. Jenkins, and Y. C. Liu. 2002. Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation. Nat. Immunol. 3: 281-287.
20. Nurieva, R. I., S. Zheng, W. Jin, Y. Chung, Y. Zhang, G. J. Martinez, J. M. Reynolds, S. L. Wang, X. Lin, S. C. Sun, et al. 2010. The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation. Immunity 32: 670-680.
21. Heissmeyer, V., F. Macián, S. H. Im, R. Varma, S. Feske, K. Venuprasad, H. Gu, Y. C. Liu, M. L. Dustin, and A. Rao. 2004. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat. Immunol. 5: 255-265.
22. Anandasabapathy, N., G. S. Ford, D. Bloom, C. Holness, V. Paragas, C. Seroogy, H. Skrenta, M. Hollenhorst, C. G. Fathman, and L. Soares. 2003. GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. Immunity 18: 535-547. (Pubitemid 36513635)
23. Venuprasad, K., C. Elly, M. Gao, S. Salek-Ardakani, Y. Harada, J. L. Luo, C. Yang, M. Croft, K. Inoue, M. Karin, and Y. C. Liu. 2006. Convergence of Itch-induced ubiquitination with MEKK1-JNK signaling in Th2 tolerance and airway inflammation. J. Clin. Invest. 116: 1117-1126.
24. Huang, H., M. S. Jeon, L. Liao, C. Yang, C. Elly, J. R. Yates, III, and Y. C. Liu. 2010. K33-linked polyubiquitination of T cell receptor-zeta regulates proteolysis-independent T cell signaling. Immunity 33: 60-70.
25. Fang, D., H. Y. Wang, N. Fang, Y. Altman, C. Elly, and Y. C. Liu. 2001. Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells. J. Biol. Chem. 276: 4872-4878.
26. Zhang, W., Y. Shao, D. Fang, J. Huang, M. S. Jeon, and Y. C. Liu. 2003. Negative regulation of T cell antigen receptor-mediated Crk-L-C3G signaling and cell adhesion by Cbl-b. J. Biol. Chem. 278: 23978-23983.
27. Venuprasad, K., H. Huang, Y. Harada, C. Elly, M. Subramaniam, T. Spelsberg, J. Su, and Y. C. Liu. 2008. The E3 ubiquitin ligase Itch regulates expression of transcription factor Foxp3 and airway inflammation by enhancing the function of transcription factor TIEG1. Nat. Immunol. 9: 245-253.
28. Su, L., N. Lineberry, Y. Huh, L. Soares, and C. G. Fathman. 2006. A novel E3 ubiquitin ligase substrate screen identifies Rho guanine dissociation inhibitor as a substrate of gene related to anergy in lymphocytes. J. Immunol. 177: 7559-7566.
29. Lineberry, N. B., L. L. Su, J. T. Lin, G. P. Coffey, C. M. Seroogy, and C. G. Fathman. 2008. Cutting edge: the transmembrane E3 ligase GRAIL ubiquitinates the costimulatory molecule CD40 ligand during the induction of T cell anergy. J. Immunol. 181: 1622-1626.
30. Oksvold, M. P., S. A. Dagger, C. B. Thien, and W. Y. Langdon. 2008. The Cbl-b RING finger domain has a limited role in regulating inflammatory cytokine production by IgE-activated mast cells. Mol. Immunol. 45: 925-936.
31. Anderson, M. S., E. S. Venanzi, L. Klein, Z. Chen, S. P. Berzins, S. J. Turley, H. von Boehmer, R. Bronson, A. Dierich, C. Benoist, and D. Mathis. 2002. Projection of an immunological self shadow within the thymus by the aire protein. Science 298: 1395-1401. (Pubitemid 35346134)
32. Lin, K. Y., F. G. Guarnieri, K. F. Staveley-O'Carroll, H. I. Levitsky, J. T. August, D. M. Pardoll, and T. C. Wu. 1996. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 56: 21-26.
33. Thien, C. B., F. D. Blystad, Y. Zhan, A. M. Lew, V. Voigt, C. E. Andoniou, and W. Y. Langdon. 2005. Loss of c-Cbl RING finger function results in high-intensity TCR signaling and thymic deletion. EMBO J. 24: 3807-3819.
34. Pircher, H., K. Bürki, R. Lang, H. Hengartner, and R. M. Zinkernagel. 1989. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342: 559-561.
35. Diehl, L., A. T. den Boer, S. P. Schoenberger, E. I. van der Voort, T. N. Schumacher, C. J. Melief, R. Offringa, and R. E. Toes. 1999. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat. Med. 5: 774-779.
36. Thien, C. B., and W. Y. Langdon. 2001. Cbl: many adaptations to regulate protein tyrosine kinases. Nat. Rev. Mol. Cell Biol. 2: 294-307.
37. Kitaura, Y., I. K. Jang, Y. Wang, Y. C. Han, T. Inazu, E. J. Cadera, M. Schlissel, R. R. Hardy, and H. Gu. 2007. Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b. Immunity 26: 567-578. (Pubitemid 46756348)
38. Qiao, G., M. Lei, Z. Li, Y. Sun, A. Minto, Y. X. Fu, H. Ying, R. J. Quigg, and J. Zhang. 2007. Negative regulation of CD40-mediated B cell responses by E3 ubiquitin ligase Casitas-B-lineage lymphoma protein-B. J. Immunol. 179: 4473-4479.
39. Qu, X., K. Sada, S. Kyo, K. Maeno, S. M. Miah, and H. Yamamura. 2004. Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b. Blood 103: 1779-1786. (Pubitemid 38268972)
40. Hirasaka, K., S. Kohno, J. Goto, H. Furochi, K. Mawatari, N. Harada, T. Hosaka, Y. Nakaya, K. Ishidoh, T. Obata, et al. 2007. Deficiency of Cbl-b gene enhances infiltration and activation of macrophages in adipose tissue and causes peripheral insulin resistance in mice. Diabetes 56: 2511-2522. (Pubitemid 47523258)
41. Kojo, S., C. Elly, Y. Harada, W. Y. Langdon, M. Kronenberg, and Y. C. Liu. 2009. Mechanisms of NKT cell anergy induction involve Cbl-b-promoted monoubiquitination of CARMA1. Proc. Natl. Acad. Sci. USA 106: 17847-17851.
42. Harada, Y., C. Elly, G. Ying, J. H. Paik, R. A. Depinho, and Y. C. Liu. 2010. Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J. Exp. Med. 207: 1381-1391.